UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This experimental study evaluates the effects of a series of intensive drug regimens as
initial treatment for Multiple Myeloma followed by 2 bone marrow transplantations 4-6 months
apart in support of high-dose Melphalan, followed by Interferon treatment indefinitely.